Welcome to the University of Colorado School of Medicine Hematology Division. The Hematology Division provides clinical care for all blood disorders, maintains active research programs and actively educates all levels of trainees; students to mentoring post-doctoral fellows.
The Division of Hematology consists of four full-time faculty members at University of Colorado Hospital. A close and collegial relationship exists with the hematologists at the Denver Veterans’ Administration Hospital and Denver Health as well as the Division of Medical Oncology, which makes it possible to sponsor a joint fellowship program and a joint attending program for the hematology-oncology service at University of Colorado Hospital.
Financial support for clinical and basic research is provided by standard NIH grants and patent royalties. Dr. Seligman has established the importance of iron transport and utilization by malignant cells as well as the utility of measuring soluble plasma transferrin receptor levels in the diagnosis of iron deficiency. Drs. Stabler and Allen have worked together in establishing new methods for the diagnosis of vitamin B12 and folate deficiency and have contributed to the growing awareness of the importance of homocysteine as an independent risk factor for vascular disease. Dr. Hassell is interested in the pathogenesis of sickle cell crisis and the recognition of new clinical entities in the fields of coagulation and endothelial cell function.
Faculty members attend on the joint hematology-oncology services at University of Colorado Hospital. They provide expert hematology consultation for the University Hospital. They attend hematology and oncology clinics at the Anschutz Cancer Pavilion. Dr. Hassell provides continuity care for patients with sickle cell anemia in both the inpatient and outpatient setting and Dr. Stabler provides similar service for patients with hemophilia. Dr. Hassell is also the physician in charge of the special anti-coagulation clinic.
Educational activities include teaching the hematology section of the freshman pathophysiology course, interactions with medical students during hematology-oncology electives in the third and fourth years and interactions with housestaff and clinical fellows in both the inpatient and outpatient setting.